Abstract:<p>Chronic kidney disease (CKD) is an increasing major public health problem worldwide. And CKD shares numerous phenotypic similarities with kidney as well as systemic ageing. Cellular senescence is mainly characterized by a stable cell cycle arrest, senescence-associated secretory phenotype (SASP) and senescent cell anti-apoptotic pathways (SCAPs). Herein, the regulations and the internal mechanisms of cellular senescence will be discussed. Meanwhile, efforts are made to give a comprehensive overview of the recent advances of the implication of cellular senescence in CKD. To date, numerous studies have focused on the effects of ageing risk factors in kidney and thereby trying to interrupt the kidney ageing processes with senolytics. Interestingly, some of them showed enormous clinical application potentials. Therefore, senotherapeutics can be applied as novel potential strategies for the treatment of CKD.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of cellular senescence in the progression of Chronic Kidney Disease (CKD) and its therapeutic potential. Specifically, the paper focuses on the following aspects: 1. **Regulation and Mechanisms of Cellular Senescence**: The paper discusses the regulatory mechanisms of cellular senescence, including cell cycle arrest, senescence - associated secretory phenotype (SASP), and senescent cell anti - apoptotic pathways (SCAPs). 2. **The Role of Cellular Senescence in CKD**: The paper reviews the role of cellular senescence in the progression of CKD, especially its influence in the process of kidney aging. Research has found that cellular senescence may be one of the important mechanisms in the progression of CKD, because it can accelerate kidney aging, leading to pathological changes such as interstitial fibrosis, glomerulosclerosis and microvascular rarefaction. 3. **Aging - Promoting Factors**: The paper explores in detail the factors that promote aging, such as hyperphosphatemia, overactivation of the renin - angiotensin system, oxidative stress and inflammatory burden, telomere attrition, and deregulated nutrient - sensing. 4. **Defects in Anti - Aging Systems**: The paper also discusses the defects in anti - aging systems, such as autophagy dysregulation, reduction in Klotho expression, and dysfunction of Sirtuins family proteins. 5. **Therapeutic Potential**: Finally, the paper proposes potential therapeutic strategies targeting cellular senescence, including senolytics (clearing senescent cells), SASP inhibitors (blocking their secretome), and senomorphics (regulating their phenotype), etc. These strategies may provide new directions for the treatment of CKD. In conclusion, this paper aims to comprehensively understand the role of cellular senescence in the progression of CKD and explore new treatment strategies based on cellular senescence.

Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies